Quality of Life in Patients With Inoperable Malignant Bowel Obstruction

The primary objective of the study is to evaluate the impact on quality of life of Lanreotide Autogel 120 mg in combination with standard care, in comparison to the standard care alone, in subjects affected by inoperable malignant bowel obstruction.

Related Clinical Trials